Holdings (Monthly)
Guide ↗
iShares Health Innovation Active ETF
· BlackRock ETF Trust| # | Name | Ticker | Since | Shares | Value | % Port | Cat |
|---|---|---|---|---|---|---|---|
| 1 | BlackRock Funds III | 066922519 | Apr 2024 | 403,509 | $404K | 4.06% | STIV |
| 2 | Johnson & Johnson | 478160104 | Jan 2026 | 1,561 | $355K | 3.57% | EC |
| 3 | Gilead Sciences Inc | 375558103 | Jan 2026 | 2,155 | $306K | 3.08% | EC |
| 4 | Exact Sciences Corp | 30063P105 | Apr 2024 | 2,857 | $292K | 2.94% | EC |
| 5 | Medtronic PLC | 000000000 | Apr 2024 | 2,818 | $290K | 2.92% | EC |
| 6 | Guardant Health Inc | 40131M109 | Apr 2024 | 2,392 | $273K | 2.74% | EC |
| 7 | Merck & Co Inc | 58933Y105 | Apr 2024 | 2,402 | $265K | 2.66% | EC |
| 8 | Roche Holding AG | 000000000 | Apr 2024 | 574 | $261K | 2.63% | EC |
| 9 | Edwards Lifesciences Corp | 28176E108 | Apr 2024 | 3,008 | $245K | 2.46% | EC |
| 10 | IQVIA Holdings Inc | 46266C105 | Jan 2026 | 960 | $221K | 2.22% | EC |
| 11 | BLACKROCK CASH FUNDS TREASURY SL AGENCY SHARES | 066922477 | Apr 2024 | 220,000 | $220K | 2.21% | STIV |
| 12 | Moderna Inc | 60770K107 | Jan 2026 | 4,989 | $220K | 2.21% | EC |
| 13 | Novartis AG | 000000000 | Apr 2024 | 1,419 | $211K | 2.12% | EC |
| 14 | Biogen Inc | 09062X103 | Apr 2024 | 1,163 | $209K | 2.11% | EC |
| 15 | Natera Inc | 632307104 | Jan 2026 | 896 | $207K | 2.08% | EC |
| 16 | Genmab A/S | 000000000 | Apr 2024 | 605 | $197K | 1.98% | EC |
| 17 | Illumina Inc | 452327109 | Jan 2026 | 1,258 | $182K | 1.83% | EC |
| 18 | Agilent Technologies Inc | 00846U101 | Jan 2026 | 1,345 | $180K | 1.81% | EC |
| 19 | Amgen Inc | 031162100 | Apr 2024 | 488 | $167K | 1.68% | EC |
| 20 | Danaher Corp | 235851102 | Apr 2024 | 714 | $156K | 1.57% | EC |
| 21 | Repligen Corp | 759916109 | Apr 2024 | 1,040 | $155K | 1.56% | EC |
| 22 | Thermo Fisher Scientific Inc | 883556102 | Apr 2024 | 251 | $145K | 1.46% | EC |
| 23 | Lonza Group AG | 000000000 | Apr 2024 | 212 | $144K | 1.45% | EC |
| 24 | Sartorius AG | 000000000 | Apr 2024 | 514 | $144K | 1.45% | EP |
| 25 | AbbVie Inc | 00287Y109 | Apr 2024 | 643 | $143K | 1.44% | EC |
| 26 | Charles River Laboratories International Inc | 159864107 | Apr 2024 | 658 | $138K | 1.39% | EC |
| 27 | Dexcom Inc | 252131107 | Apr 2024 | 1,875 | $137K | 1.38% | EC |
| 28 | Argenx SE | 04016X101 | Apr 2024 | 160 | $134K | 1.35% | EC |
| 29 | Ionis Pharmaceuticals Inc | 462222100 | Apr 2024 | 1,610 | $133K | 1.34% | EC |
| 30 | Intuitive Surgical Inc | 46120E602 | Apr 2024 | 258 | $130K | 1.31% | EC |
| 31 | Rhythm Pharmaceuticals Inc | 76243J105 | Apr 2024 | 1,209 | $124K | 1.25% | EC |
| 32 | UCB SA | 000000000 | Apr 2024 | 404 | $123K | 1.24% | EC |
| 33 | Neurocrine Biosciences Inc | 64125C109 | Apr 2024 | 865 | $118K | 1.18% | EC |
| 34 | Bio-Techne Corp | 09073M104 | Apr 2024 | 1,826 | $117K | 1.18% | EC |
| 35 | QIAGEN NV | 000000000 | Apr 2024 | 2,162 | $116K | 1.17% | EC |
| 36 | Bridgebio Pharma Inc | 10806X102 | Apr 2024 | 1,472 | $114K | 1.14% | EC |
| 37 | Hologic Inc | 436440101 | Apr 2024 | 1,474 | $110K | 1.11% | EC |
| 38 | Insulet Corp | 45784P101 | Jan 2026 | 415 | $106K | 1.07% | EC |
| 39 | Boston Scientific Corp | 101137107 | Apr 2024 | 1,130 | $106K | 1.06% | EC |
| 40 | AstraZeneca PLC | 046353108 | Apr 2024 | 1,056 | $98K | 0.99% | EC |
| 41 | Wuxi Biologics Cayman Inc | 000000000 | Apr 2024 | 20,500 | $97K | 0.98% | EC |
| 42 | Exelixis Inc | 30161Q104 | Apr 2024 | 2,281 | $94K | 0.95% | EC |
| 43 | Eisai Co Ltd | 000000000 | Apr 2024 | 3,300 | $92K | 0.93% | EC |
| 44 | Bristol-Myers Squibb Co | 110122108 | Jan 2026 | 1,620 | $89K | 0.90% | EC |
| 45 | Teva Pharmaceutical Industries Ltd | 881624209 | Jan 2026 | 2,298 | $78K | 0.79% | EC |
| 46 | Penumbra Inc | 70975L107 | Apr 2024 | 208 | $74K | 0.75% | EC |
| 47 | Abbott Laboratories | 002824100 | Jan 2026 | 632 | $69K | 0.70% | EC |
| 48 | Protagonist Therapeutics Inc | 74366E102 | Apr 2024 | 745 | $61K | 0.61% | EC |
| 49 | Galderma Group AG | 000000000 | Apr 2024 | 315 | $59K | 0.59% | EC |
| 50 | Nuvalent Inc | 670703107 | Apr 2024 | 561 | $58K | 0.58% | EC |
| 51 | Waters Corp | 941848103 | Apr 2024 | 153 | $57K | 0.57% | EC |
| 52 | Medline Inc | 58507V107 | Jan 2026 | 1,274 | $56K | 0.57% | EC |
| 53 | Elanco Animal Health Inc | 28414H103 | Apr 2024 | 2,280 | $55K | 0.55% | EC |
| 54 | BeOne Medicines Ltd | 07725L102 | Apr 2024 | 161 | $55K | 0.55% | EC |
| 55 | MBX Biosciences Inc | 55287L101 | Jan 2026 | 1,392 | $51K | 0.52% | EC |
| 56 | Tempus AI Inc | 88023B103 | Jan 2026 | 840 | $50K | 0.51% | EC |
| 57 | Terns Pharmaceuticals Inc | 880881107 | Jan 2026 | 1,425 | $49K | 0.50% | EC |
| 58 | Cencora Inc | 03073E105 | Apr 2024 | 137 | $49K | 0.50% | EC |
| 59 | Revolution Medicines Inc | 76155X100 | Apr 2024 | 506 | $49K | 0.49% | EC |
| 60 | Halozyme Therapeutics Inc | 40637H109 | Apr 2024 | 680 | $49K | 0.49% | EC |
| 61 | McKesson Corp | 58155Q103 | Apr 2024 | 58 | $48K | 0.49% | EC |
| 62 | Axsome Therapeutics Inc | 05464T104 | Apr 2024 | 261 | $48K | 0.48% | EC |
| 63 | Bio-Rad Laboratories Inc | 090572207 | Apr 2024 | 162 | $48K | 0.48% | EC |
| 64 | Pfizer Inc | 717081103 | Jan 2026 | 1,794 | $47K | 0.48% | EC |
| 65 | Alkermes PLC | 000000000 | Apr 2024 | 1,392 | $47K | 0.47% | EC |
| 66 | Cogent Biosciences Inc | 19240Q201 | Jan 2026 | 1,273 | $46K | 0.46% | EC |
| 67 | Incyte Corp | 45337C102 | Apr 2024 | 434 | $43K | 0.44% | EC |
| 68 | Stoke Therapeutics Inc | 86150R107 | Apr 2024 | 1,416 | $43K | 0.43% | EC |
| 69 | EssilorLuxottica SA | 000000000 | Apr 2024 | 136 | $42K | 0.42% | EC |
| 70 | Samsung Biologics Co Ltd | 000000000 | Apr 2024 | 32 | $39K | 0.39% | EC |
| 71 | Arcellx Inc | 03940C100 | Jan 2026 | 561 | $38K | 0.39% | EC |
| 72 | LB Pharmaceuticals Inc | 50180M108 | Jan 2026 | 1,779 | $38K | 0.38% | EC |
| 73 | Arcus Biosciences Inc | 03969F109 | Apr 2024 | 1,808 | $38K | 0.38% | EC |
| 74 | Denali Therapeutics Inc | 24823R105 | Apr 2024 | 1,729 | $38K | 0.38% | EC |
| 75 | Vertex Pharmaceuticals Inc | 92532F100 | Apr 2024 | 73 | $34K | 0.35% | EC |
| 76 | Zealand Pharma A/S | 000000000 | Apr 2024 | 498 | $33K | 0.34% | EC |
| 77 | Lantheus Holdings Inc | 516544103 | Jan 2026 | 489 | $33K | 0.33% | EC |
| 78 | Ventyx Biosciences Inc | 92332V107 | Jan 2026 | 2,312 | $32K | 0.32% | EC |
| 79 | Bruker Corp | 116794108 | Apr 2024 | 698 | $31K | 0.31% | EC |
| 80 | RadNet Inc | 750491102 | Apr 2024 | 433 | $30K | 0.31% | EC |
| 81 | Viridian Therapeutics Inc | 92790C104 | Jan 2026 | 919 | $30K | 0.31% | EC |
| 82 | Kiniksa Pharmaceuticals International Plc | 000000000 | Apr 2024 | 689 | $30K | 0.30% | EC |
| 83 | Akeso Inc | 000000000 | Apr 2024 | 2,000 | $28K | 0.28% | EC |
| 84 | Novocure Ltd | 000000000 | Apr 2024 | 2,144 | $27K | 0.27% | EC |
| 85 | Edgewise Therapeutics Inc | 28036F105 | Jan 2026 | 937 | $26K | 0.27% | EC |
| 86 | Bright Minds Biosciences Inc | 10919W405 | Jan 2026 | 339 | $26K | 0.27% | EC |
| 87 | Agios Pharmaceuticals Inc | 00847X104 | Jan 2026 | 892 | $24K | 0.25% | EC |
| 88 | Apogee Therapeutics Inc | 03770N101 | Jan 2026 | 368 | $24K | 0.24% | EC |
| 89 | Olema Pharmaceuticals Inc | 68062P106 | Jan 2026 | 921 | $24K | 0.24% | EC |
| 90 | PTC Therapeutics Inc | 69366J200 | Apr 2024 | 308 | $23K | 0.23% | EC |
| 91 | Cytokinetics Inc | 23282W605 | Jan 2026 | 360 | $23K | 0.23% | EC |
| 92 | Alumis Inc | 022307102 | Jan 2026 | 923 | $23K | 0.23% | EC |
| 93 | Beam Therapeutics Inc | 07373V105 | Apr 2024 | 810 | $22K | 0.23% | EC |
| 94 | Viking Therapeutics Inc | 92686J106 | Apr 2024 | 757 | $22K | 0.22% | EC |
| 95 | Harmony Biosciences Holdings Inc | 413197104 | Jan 2026 | 578 | $21K | 0.21% | EC |
| 96 | BioMarin Pharmaceutical Inc | 09061G101 | Apr 2024 | 338 | $19K | 0.19% | EC |
| 97 | Immunocore Holdings PLC | 45258D105 | Apr 2024 | 586 | $19K | 0.19% | EC |
| 98 | Daiichi Sankyo Co Ltd | 000000000 | Apr 2024 | 1,000 | $18K | 0.18% | EC |
| 99 | Maze Therapeutics Inc | 578784100 | Jan 2026 | 397 | $17K | 0.17% | EC |
| 100 | Oruka Therapeutics Inc | 687604108 | Jan 2026 | 504 | $17K | 0.17% | EC |
| 101 | Disc Medicine Inc | 254604101 | Jan 2026 | 209 | $16K | 0.16% | EC |
| 102 | Nuvation Bio Inc | 67080N101 | Apr 2024 | 3,067 | $16K | 0.16% | EC |
| 103 | Intellia Therapeutics Inc | 45826J105 | Jan 2026 | 1,200 | $16K | 0.16% | EC |
| 104 | Upstream Bio Inc | 91678A107 | Jan 2026 | 507 | $16K | 0.16% | EC |
| 105 | Immunome Inc | 45257U108 | Jan 2026 | 640 | $16K | 0.16% | EC |
| 106 | Dyne Therapeutics Inc | 26818M108 | Apr 2024 | 880 | $16K | 0.16% | EC |
| 107 | Erasca Inc | 29479A108 | Jan 2026 | 1,460 | $15K | 0.15% | EC |
| 108 | Summit Therapeutics Inc | 86627T108 | Jan 2026 | 1,041 | $15K | 0.15% | EC |
| 109 | Scholar Rock Holding Corp | 80706P103 | Jan 2026 | 336 | $15K | 0.15% | EC |
| 110 | Arvinas Inc | 04335A105 | Apr 2024 | 1,040 | $14K | 0.14% | EC |
| 111 | BioNTech SE | 09075V102 | Jan 2026 | 122 | $14K | 0.14% | EC |
| 112 | Monte Rosa Therapeutics Inc | 61225M102 | Apr 2024 | 642 | $13K | 0.13% | EC |
| 113 | Enliven Therapeutics Inc | 29337E102 | Jan 2026 | 492 | $13K | 0.13% | EC |
| 114 | WaVe Life Sciences Ltd | 000000000 | Apr 2024 | 865 | $11K | 0.11% | EC |
| 115 | Aktis Oncology Inc | 01021M104 | Jan 2026 | 531 | $11K | 0.11% | EC |
| 116 | ORIC Pharmaceuticals Inc | 68622P109 | Jan 2026 | 1,042 | $11K | 0.11% | EC |
| 117 | EyePoint Inc | 30233G209 | Jan 2026 | 760 | $10K | 0.10% | EC |
| 118 | Avidity Biosciences Inc | 05370A108 | Jan 2026 | 138 | $10K | 0.10% | EC |
| 119 | uniQure NV | 000000000 | Apr 2024 | 437 | $10K | 0.10% | EC |
| 120 | KalVista Pharmaceuticals Inc | 483497103 | Jan 2026 | 633 | $10K | 0.10% | EC |
| 121 | Ascendis Pharma A/S | 04351P101 | Jan 2026 | 43 | $10K | 0.10% | EC |
| 122 | Enanta Pharmaceuticals Inc | 29251M106 | Jan 2026 | 712 | $9K | 0.09% | EC |
| 123 | REGENXBIO Inc | 75901B107 | Apr 2024 | 816 | $9K | 0.09% | EC |
| 124 | Dianthus Therapeutics Inc | 252828108 | Jan 2026 | 167 | $9K | 0.09% | EC |
| 125 | Abivax SA | 00370M103 | Jan 2026 | 80 | $9K | 0.09% | EC |
| 126 | Kodiak Sciences Inc | 50015M109 | Jan 2026 | 322 | $7K | 0.07% | EC |
| 127 | Ocular Therapeutix Inc | 67576A100 | Jan 2026 | 776 | $7K | 0.07% | EC |
| 128 | Vir Biotechnology Inc | 92764N102 | Jan 2026 | 905 | $7K | 0.07% | EC |
| 129 | Vor BioPharma Inc | 929033207 | Jan 2026 | 488 | $6K | 0.06% | EC |
| 130 | Voyager Therapeutics Inc | 92915B106 | Apr 2024 | 1,560 | $6K | 0.06% | EC |
| 131 | Biohaven Ltd | 000000000 | Apr 2024 | 505 | $6K | 0.06% | EC |
| 132 | Allogene Therapeutics Inc | 019770106 | Jan 2026 | 3,144 | $6K | 0.06% | EC |
| 133 | Nyxoah SA | 000000000 | Apr 2024 | 1,210 | $6K | 0.06% | EC |
| 134 | Corvus Pharmaceuticals Inc | 221015100 | Jan 2026 | 225 | $5K | 0.05% | EC |
| 135 | TScan Therapeutics Inc | 89854M101 | Apr 2024 | 4,466 | $5K | 0.05% | EC |
| 136 | Autolus Therapeutics PLC | 05280R100 | Apr 2024 | 3,256 | $4K | 0.04% | EC |
| 137 | 4D Molecular Therapeutics Inc | 35104E100 | Apr 2024 | 472 | $4K | 0.04% | EC |
| 138 | Avalo Therapeutics Inc | 05338F306 | Jan 2026 | 272 | $4K | 0.04% | EC |
| 139 | Rezolute Inc | 76200L309 | Jan 2026 | 972 | $3K | 0.03% | EC |
| 140 | Bicycle Therapeutics PLC | 088786108 | Apr 2024 | 392 | $3K | 0.03% | EC |
| 141 | Gossamer Bio Inc | 38341P102 | Jan 2026 | 546 | $1K | 0.01% | EC |
| 142 | CONTRA ABIOMED INC | 003CVR016 | Apr 2024 | 246 | $571 | 0.01% | — |
| 143 | CONTRA MIRATI THERAPEU | 604CVR027 | Apr 2024 | 334 | $264 | 0.00% | — |
| 144 | CONTRA BLUEPRINT MEDIC | 096CVR048 | Jan 2026 | 110 | $108 | 0.00% | — |
| 145 | CONTRA VIGIL NEUROSCIE | 926CVR010 | Jan 2026 | 484 | $24 | 0.00% | — |
| 146 | CONTRA FREQUENCY THERA | 358CVR025 | Apr 2024 | 420 | $0 | 0.00% | — |